# PharmStars Spring 2025 Accelerator
Source: https://www.keypedia.com/media/pharmstars-spring-2025-accelerator
Type: press_release
Published: July 10, 2025
Updated: March 12, 2026
Authors: George Kwiecinski
> Global Key Solutions completes PharmStars Spring 2025 Accelerator, joining 11 digital health startups to innovate for pharma.
---
# Global Key Solutions Celebrates PharmStars Spring 2025 Accelerator Graduation
We’re proud to announce that Global Key Solutions has successfully completed the Spring 2025 PharmStars Accelerator! As one of the 12 digital health startups selected, GKSC participated in the industry’s premier pharma-focused accelerator designed to foster innovation and strategic partnerships between startups and the pharmaceutical sector.
PharmStars officially announced the Spring 2025 cohort graduates in a [press release](https://www.einpresswire.com/article/822679489/pharmstars-announces-spring-2025-graduates-12-digital-health-startups-complete-pharmstars-pharma-focused-accelerator).
The program offered exclusive opportunities for mentorship, education, and direct engagement with leading pharmaceutical firms. Over the course of several months, we refined our go-to-market strategy, aligned our product roadmap with pharma pain points, and formed valuable new partnerships.
> “The activities within the PharmStars program elevated the startups to truly understand the pharmaceutical landscape. I was impressed to see the dedication, maturity, and scale of all the cohort companies.”
> — [Dr. Ligia Zubik](https://www.linkedin.com/in/ligia-zubik/), advisor invited to the program by the Global Key Solutions team
*From left to right: [Amir Zur](https://www.linkedin.com/in/amir-zur-200ba53/), [Naomi Friend, Ph.D.](https://www.linkedin.com/in/nfried/), [Zephaniah Odidika](https://www.linkedin.com/in/zcco/), [George Kwiecinski](https://www.linkedin.com/in/kwiecinskigeorge/)*
## Spring 2025 Cohort
GKSC joined 11 other visionary startups in this cohort, each focused on a unique frontier of digital health:
AESOP Technology – Dashboard for Real-Time EHR Data Insights
Comend – Federated Marketplace of Rare Disease Advocacy Data
Compose Health – AI Content Orchestration for Market-Facing Comms
EXOSYSTEMS – Digital Biomarkers for Motor Function Assessment
Global Key Solutions – Continuously Updated Regulatory Intelligence Engine
Intercellular – miRNA-Based Cancer Monitoring via AI
LivAi – 3D Tumor Biomarkers from Routine Imaging
Meep – At-Home Biomarker Minilab for Daily Monitoring
Octozi – AI Data Cleaning and Review Platform
Preview Health – AI for Complete Metabolic Profiling
PulManage – High-Quality Remote Spirometry at Scale
Vako – Advocacy Group Enablement and Patient Support Platform
*George Kwiecinski presenting to six member companies of the PharmStars Spring 2025 program*
## What This Means for GKSC
Ensuring the delivery of high-quality medicines and health products has never been more critical. Beyond the traditional pressures of passing FDA inspections, companies are now expected to contribute to broader national security objectives and supply chain resilience through excellence in quality.
At Global Key Solutions, this is our mission. Completing the PharmStars accelerator reinforced the urgency and importance of innovating at the intersection of compliance, data, and pharmaceutical performance.
> **GKS Messaging Developed with PharmStars**
**Tagline**
>**Continuously Updated Information Engine to Access Industry-Wide Compliance and Regulatory Data**
**Company Description**
>Pharmaceutical companies face increasing regulatory pressure beyond routine inspections. The issuance rate of enforcement actions like FDA 483s and Warning Letters has doubled since 2019. Vigilant monitoring and proactive strategies are essential to stay compliant with shifting regulatory expectations. While regulatory, compliance, and quality data is available, it is often fragmented, outdated, lacks context, and is difficult to synthesize into actionable information.
>Our proprietary engine unifies regulatory and compliance data across the FDA-regulated landscape, providing searchable and actionable insights for quality, operations, and leadership teams. Built by a team of former FDA reviewers and global quality leaders, our engine contains over 5,000 charts, 12,000 documents, and 300,000+ inspection observations and citations, all systematically categorized and continuously updated. A top 10 drug and device manufacturer is using our platform to develop data-driven compliance plans, including preventive strategy, continuous improvements, Root Cause Analysis (RCA), and effective Corrective and Preventive Actions.
>Our information engine has also been used to prepare for FDA inspections and audits. In 2025, we will add document citation capabilities, which will recommend updates to internal regulatory documents and workflows whenever FDA policies are revised.
Stay tuned for more partnership news coming soon!